Table 1.

Patient characteristics at baseline.

Patient characteristic		All		Neoadjuvant = No		Neoadjuvant = Yes		p-Value
		N	Mean (SD)	N	Mean (SD)	N	Mean (SD)
Age		124	58.1 (10.0)	93	57.6 (10.2)	30	60.1 (9.1)	0.237
BMI		124	27.1 (6.4)	93	27.6 (6.5)	30	25.6 (5.9)	0.135
		N	%	N	%	N	%	p-Value
Study arm	PCOA	64	52	54	58	10	33	0.018
	Control	59	48	39	42	20	67
Ethnicity	Hispanic or Latino	2	2	2	2	0	0	0.508
	Not Hispanic or Latino	119	97	90	97	29	97
	Not reported	2	2	1	1	1	3
Race	Non-white	10	8	6	6	4	13	0.230
	White	113	92	87	94	26	87
Insurance	Medicaid	5	4	4	4	1	3	0.504
	Medicare	30	24	24	26	6	20
	Private	81	66	58	62	23	77
	Other	5	4	50	5	0	0
	None	2	2	2	2	0	0
Primary site	Fallopian tube	9	7	7	8	2	7	0.864
	Ovary	103	84	77	83	26	87
	Peritoneum	11	9	9	10	2	7
Stage	II	7	6	7	8	0	0	0.004
	III	102	83	80	86	22	73
	IV	14	11	6	6	8	27
Grade (N = 98)	1	4	4	4	6	0	0	0.383
	2	5	5	3	4	2	8
	3	89	91	65	90	24	92
Surgical complications	No	106	86	79	85	27	90	0.486
	Yes	17	14	14	15	3	10
Colon resection	No	88	72	61	66	27	90	0.010
	Yes	35	28	32	34	3	10
IP port at surgery	No	50	41	36	39	14	47	0.440
	Yes	73	59	57	61	16	53
Residual disease (%)	0	82	67	63	68	19	63	0.021
	1–2	28	23	24	26	4	13
	≥ 5	13	11	6	6	7	23
Performance status	0	62	50	50	54	12	40	0.190
	1	59	48	41	44	18	60
	2	2	2	2	2	0	0
BRCA	Negative	9	7	3	3	6	20	n/a
	Positive	7	6	2	2	5	17
	Unknown	107	87	88	95	19	63
Health resemblance	Healthier	104	85	80	86	24	80	0.427
	Less healthy	19	15	13	14	6	20
MD recommendation	IP	87	72	66	73	21	70	0.789
	IV	34	28	25	27	9	30
Treatment decision	IP	80	66	60	65	20	67	0.885
	IV	42	34	32	35	10	33